Bill T. Ameredes, PhD
Associate Professor, Division of Pulmonary Critical Care & Sleep Medicine
Bill T. Ameredes, PhD
Associate Professor, Medicine
Associate Professor, Biochemistry and Molecular Biology
UT Distinguished Teaching Professor
Director, KL2 Scholars Program, NIH/NCATS CTSA
Director, Environmental Inhalation Exposure Facility
Director, NIEHS Environmental Toxicology Training Program
Vice Chair, Academy of Research Mentors
Class of 1947 UTMB School of Medicine Memorial Endowed Professor
William C. Levin Chair, Environmental Toxicology
University of Texas Medical Branch
Division of Pulmonary, and Critical Care Medicine
Medical Research Building 8.104
301 University Blvd.
Galveston, TX 77555-1083
|Degree/Training Completed||Year||Name & Location|
|Ph.D.||1989||Ohio State University, Columbus, Ohio|
|Post-Doctoral Training||1990||University of Florida, Gainesville, FL|
|Post-Doctoral Fellowship||1992||University of Florida, Gainesville, FL|
- Airway smooth muscle biology and beta-receptor regulation
- Immune/inflammatory cytokine responses of the airway
- Beta-agonist regulation of MAPK mechanisms
- Role of carbon monoxide in airway inflammation
- Role of nitric oxide in airway inflammation
- Sokol K, Sur S, Ameredes BT. Inhaled environmental allergens and toxicants as determinants of the asthma phenotype. Chapter 4 in: Heterogeneity in Asthma: Translational Profiling and Phenotyping, AR Brasier, ed., Advances in Experimental Medicine and Biology, Vol. 795, 43-74, XIV, 354 p. 33 illus., 25 illus. in color; Springer, New York, NY. E-book ISBN 978-1-4614-8603-9; Hardcover ISBN 978-1-4614-8602-2, 2014.
- Terasaki J, Nishi SPE, Ameredes BT, Sharma G. Arformoterol: Rationale for use in chronic obstructive pulmonary disease. Clin. Invest. 4(5), 429–439, 2014
- Ruiz, J, Ameredes, BT. The cellular effects of carbon monoxide in the airway. Curr Mol Med 13(1):94-108, 2013.
- Devekar, R., Ameredes BT, Calhoun WJ. Symptom-based controller therapy: a new paradigm for asthma treatment. Curr Allergy Asthma Reports Oct;13(5): 427-33. doi: 10.1007/s11882-013-0375-7, 2013.
- Calhoun WJ, Ameredes BT, King TS, Icitovic N, Bleecker ER, Castro M, Cherniack RM, Chinchilli VM, Craig T, Denlinger L, DiMango EA, Engle LL, Fahy JV, Grant JA, Israel E, Jarjour N, Kazani SD, Kraft M, Kunselman SJ, Lazarus SC, Lemanske Jr RF, Lugogo N, Martin RM, Meyers DA, Moore WC, Pascual R, Peters SP, Ramsdell J, Sorkness CA, Sutherland ER, Szefler SJ, Wasserman SI, Walter MJ, Wechsler ME, Boushey HA. Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial. JAMA Sept 12, 308(10): 987-997. 2012.
- Ameredes, BT. Beta-2-receptor regulation of immunomodulatory proteins in airway smooth muscle. Frontiers in Bioscience (Schol Ed). 3:643-54, 2011.
- Ameredes, BT. Translating airway biomarker information into practice: from theoretical science to applied medicine. Pulm Pharmacol Ther. Sep 30. [Epub ahead of print] 2010.
- Ogawa Y, Duru EA, Ameredes BT. Role of IL-10 in the resolution of airway inflammation. Curr Mol Med. 8(5): 437-445, 2008.
The department of internal medicine is developing evidence based clinical protocols which will be available in EPIC (as order sets) for use when admitting patients with these diagnoses. Their AIM is to standardize care and decrease length of stay and readmission rates.Currently available protocols are:
- CAP - Community Acquired Pneumonia Orderset
- Congestive Heart Failure (CHF)
- Chronic Obstructive Pulmonary Disease (COPD)
- Diabetic Ketoacidosis Adult, ICU
- General Medicine Admission
- Immunodeficiency Flow Panel
- MICU/CCU Admission Order Set
- Oral Analgesic Medicaitons
- Parenteral Opioids
- Sepsis, Adult ICU
- 111 - Stroke Alert
- 112 - Stroke Activation
- 300086 - Stroke Floor Admission
- 3000000001 - Stroke Critical care without tPA
- 300088 Stroke - Transfer from Critical care to floor
- 3004002 - Stroke Discharge
All protocols can be found in the EPIC order set section.
The department of Internal Medicine has a large role in the Meaningful Use Initiative. Our participation is key for the success of the initiative. Please visit the meaningful use website for important communication and updates from the Meaningful Use Initiative.